Alivus Life Sciences Ltd.

Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, Alivus Life Sciences has informed that the Board at its meeting held today approved the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2024. The said meeting of the Board commenced at 12:30 pm and concluded at 2:10 pm. The copy of the said results and Limited Review Report of the Auditors is enclosed. These are also being made available on the website of the Company at www.alivus.com.

The above information is a part of company’s filings submitted to BSE.